AC
Abraham Ceesay sold $143K of RAPP stock
Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP), sold 4,522 shares of RAPP stock worth $143K, per an SEC Form 4 filed Oct 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 6, 2026, 2 days before it was made public.
RAPP has moved -24.3% since the trade date, from $31.15 to $23.59 (Nov 19, 2026 close).
- Traded
- Oct 6, 2026
- Disclosed
- Oct 8, 2026
- Filing delay
- 2 days
- Price since
- -24.3%
- Role
- Chief Executive Officer
- Source
- SEC Form 4